configuration around the enzyme active site (4, 5) . They are typically encoded by plasmids that can be exchanged between bacterial species (7, 8) . It is also reported that the predominant types of ESBLs in K. pneumoniae are SHV type followed by TEM and CTX-M (2, 4, 9, 10). The prevalence of ESBL producing K. pneumoniae varies around the world and has been reported to be around 1-5% in European countries, 7.5% in North America, 13 .3% in Europe, 22 .4% in Asia Pacific Rim, 44% in Latin America, 48.5% in Turkey, 51% in China, 71.4% in Mexico and 72% in India (4, (11) (12) (13) . The prevalence of ESBL producing K. pneumoniae in Iran is reported to range from 19.6 to 75% with SHV as the dominant type (14) (15) (16) (17) (18) . We studied ESBL production in the urinary isolates of Klebsiella pneumoniae in relation to the presence of SHV, TEM and CTX-M -lactamase genes among the isolates.
Materials and methods
Fifty one urinary isolates of K. pneumoniae were chosen from a collection of urinary isolates between March and August 2008 from two hospitals in Tehran (Taleghani and Imam Hussein). The isolates were tested for antimicrobial susceptibility by the disc diffusion method according to the NCCLS guidelines (19) . The antibiotic discs were obtained from Padtan Teb (Tehran, Iran) and the following antibiotics were used: amoxicillin (30 g), amikacin (30g), ceftazidime (30g), cefotaxime (30g), cefteriaxon (30g), ceftizoxime (30g), gentamicin (10g), ciprofloxacin (10g), and nitrofurantoin (300g). Minimum inhibitory concentrations were also measured for 5 antibiotics using the broth microdilution method and the NCCLS guidelines (20). The double disc synergy test (DDST) was used to detect ESBL production (21) . Briefly, the organisms were swabbed on to Mueller-Hinton agar plates (as performed for disc diffusion), an amoxiclav disc (20 + 10 g) was placed in the center of the plate and ceftizoxime (30g), cefotaxime (30g), cefteriaxon (30g) discs were placed 15 mm away from the central disc. The plates were incubated at 37 o C for up to 24 h. An increase of > 5 mm inhibition zone for antibiotics around the amoxyclav disc compared to the cephalosporin discs alone was considered ESBL production. ESBL production was further confirmed by the phenotypic confirmatory test (PCT) using ceftazidime and ceftazidime/clavlanic acid (22) . Genomic DNA was prepared from overnight cultures grown on Lauria-Bertani broth [LB] (Hi-Media, Mumbai, India) by inoculating a single colony into 100 l of double distilled water and boiling for 10 min. An equal volume of chloroform: isoamyl alcohol (24:1 v/v) was added, mixed by end over end rotation and the mixture was centrifuged at 8000 x g for 15 min. The upper layer was then used in the PCR reaction mixtures (21) . PCR amplification was carried out with specific primers for bla SHV 
Results
The antibiotic susceptibility profile measured by disc diffusion is shown in figure 1 . As observed the highest rate of resistance was found for amoxicillin (96.08 %) and the lowest for gentamicin and ciprofloxacin (29.42 %). Among the broad spectrum -lactam antibiotics, the level of resistance ranged between 37.25 to 41.17 %. The MIC results showed 88.23% resistance to cefotaxime, 83.35% to ceftriaxone, 82.35% to ceftazidime, 50.98% to ceftizoxime and 47.06% to ciprofloxacin. These values were much higher compared to the resistance patterns obtained by disc diffusion. However, when the numbers of resistant and intermediately resistant organisms were compiled, there was total agreement between the two phenotypic tests. Figure 2 shows the PCR amplification products of -lactamase genes. The results showed that 22 isolates (43.14%) carried the bla SHV 
Discussion
Klebsiella pneumoniae has rapidly become the most common ESBL producing organism, making its eradication difficult from high risk wards such as intensive care units. In our study, 27.45% of the urinary isolates of K. pneumoniae were ESBL producers. Despite the fact that a small number of isolates were tested, ESBL production among our isolates was higher than a study performed in Semnan, Iran where ESBL production in urinary isolates was reported to be 19.6% (17) . On the other hand, our results showed a lower rate of ESBL production compared to most of the other studies carried out in Iran and other parts of the Middle or Far East (11) (12) (13) (14) (15) (16) (17) (18) . The prevalence rates of ESBL production are different in different countries or different parts of each country and are very much dependent upon antibiotic policies in every region. The conventional disc diffusion method does not usually allow for routine differentiation of ESBL producing strains. Several methods have been devised to differentiate between ESBL and non-ESBL producers among which, the double disc diffusion test has been reported to be the most discriminating (25) (26) . Also, molecular detection methods such as PCR have been used for molecular differentiation of β-lactamase producing isolates. However, most of the studies performed, aim for the detection of the more commonly occurring β-lactamase genes such as the TEM and SHV family and it is not practical to screen for a large number of -lactamase genes. In a study carried out in Taiwan, a correlation was reported between phenotypic resistance to cefotaxime, ceftazidime and ceftriaxone in ESBL producing K. pneumoniae isolates and presence of bla SHV, bla CTX-M and bla VEB-1 like genes but not bla TEM (22) . Our results showed no relation between presence of TEM, SHV and CTX-M -lactamase genes with -lactamase production or ESBL phenotype. Presence of ESBLs can be masked by the expression of chromosomal or plasmid mediated AmpC -lactamases. Also, ESBL producing strains with AmpC -lactamases can cause a false negative in ESBL detection (25) (26) (27) . More importantly, expression of -lactamase genes depend upon the environmental conditions such as the presence of antibiotics and gene presence shown by PCR does not necessarily indicate its expression.
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